in 1993, we considered three possibilities on how the okadaic acid pathway is related to human cancer: (1) exposure to the okadaic acid class compounds, which had already been reported; (2) involvement of endogenous protein inhibitors of PP1 and PP2A in the cells - this possibility is the main topics of this review article. Here, PTPA is linked to cancer.